Vitamin B12
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- B12 deficiency can cause irreversible neurological damage — subacute combined degeneration of the spinal cord is a progressive, potentially devastating consequence that can be largely prevented by early detection and treatment.
- Standard lab ranges miss functional deficiency. A B12 of 250 pg/mL may be classified as normal, but neurological symptoms and elevated homocysteine can appear at levels below 400 pg/mL. Optimal is above 500 pg/mL.
- Risk groups are large and often unaware. Vegans, vegetarians, people over 50, metformin users, and PPI users are all at significantly elevated risk and should test regularly.
- B12 and homocysteine are deeply connected. B12 is a required cofactor for homocysteine metabolism; deficiency causes homocysteine to accumulate, raising cardiovascular and dementia risk. Testing both together provides the most complete picture.
- Serum B12 has limitations as a test. It measures total B12 including inactive forms. Methylmalonic acid (MMA) and holotranscobalamin (active B12) are more sensitive markers of functional deficiency — worth testing if symptoms are present with borderline serum B12.
The Vitamin That Can Cause Irreversible Damage Before Symptoms Appear
Most nutritional deficiencies produce symptoms relatively early in their course — fatigue, weakness, visible signs that prompt investigation. Vitamin B12 deficiency is different. Its most serious consequence — progressive demyelination of the spinal cord and brain, a condition called subacute combined degeneration — can develop silently for years before neurological symptoms become apparent. By the time weakness, balance problems, cognitive impairment, or peripheral neuropathy become obvious, significant structural damage may already have occurred.
This is why testing B12 proactively — particularly in people with known risk factors — is one of the highest-value, lowest-cost actions in preventive medicine. A serum B12 test costs $15–25 and can be ordered without a physician's visit. The information it provides can prevent a condition that, once advanced, may be only partially reversible.
The scale of undetected B12 deficiency in the adult population is substantial. Data from the Framingham Offspring Study found that approximately 39% of participants had B12 levels in the "low normal" range (200–300 pg/mL) — a range associated with elevated methylmalonic acid and homocysteine, indicating functional deficiency despite technically normal serum values. 1
What B12 Does — and What Happens When It's Low
Vitamin B12 functions as a cofactor in two reactions that sit at the intersection of several critical biological pathways:
Homocysteine remethylation: B12, together with folate (as methyltetrahydrofolate), is required to convert homocysteine back to methionine. Methionine is the precursor to SAM (S-adenosylmethionine), the primary methyl donor in the body — used in DNA methylation, neurotransmitter synthesis, and dozens of other reactions. When B12 is insufficient, homocysteine accumulates (raising cardiovascular and dementia risk) and the methionine/SAM pool is depleted (impairing methylation reactions throughout the body).
Methylmalonyl-CoA metabolism: B12 (as adenosylcobalamin) is required to convert methylmalonyl-CoA to succinyl-CoA, a reaction essential for fatty acid oxidation in mitochondria and for myelin synthesis. When this reaction is impaired, odd-chain fatty acids accumulate and are incorporated into neuronal membranes, disrupting myelin structure. This is the primary biochemical mechanism behind the neurological damage of B12 deficiency.
| Category | Serum B12 | Clinical Status | Longevity Assessment |
|---|---|---|---|
| Optimal | > 600 pg/mL | Normal — upper range | Optimal — neurological and metabolic protection |
| Adequate | 400–600 pg/mL | Normal | Good — consider maintaining with diet or supplementation |
| Gray zone | 200–400 pg/mL | Normal (by standard ranges) | Borderline — functional deficiency possible; test MMA and homocysteine |
| Deficient | < 200 pg/mL | Deficient | Deficient — neurological risk; requires treatment |
Already have your lab results? See how your Vitamin B12 and other markers score on a longevity scale — in under 60 seconds.
Analyze My Biomarkers →B12 and Brain Health: The Dementia Connection
The connection between B12 status and cognitive aging is one of the more compelling areas of nutritional neuroscience. The mechanisms are multiple and well established.
First, B12 deficiency allows homocysteine to accumulate. Elevated homocysteine is an independent risk factor for dementia and Alzheimer's disease — epidemiological studies consistently find that people with higher homocysteine levels have significantly elevated dementia risk, and the OPTIMA (Oxford Project to Investigate Memory and Ageing) studies demonstrated that elevated homocysteine accelerates the rate of brain atrophy in people with mild cognitive impairment. 2
Second, B12 deficiency impairs myelin maintenance throughout the nervous system, including in the brain. Myelin is the insulating sheath around nerve fibers that enables fast, efficient signal transmission. Demyelination slows conduction and disrupts neural circuits in ways that contribute to cognitive decline.
Third, B12 is required for the synthesis of several neurotransmitters through the methylation pathway, including dopamine and serotonin precursors. Deficiency can manifest as depression, mood instability, and cognitive fog — symptoms often attributed to other causes.
The practical implication: ensuring adequate B12 status — and particularly treating the gray zone (200–400 pg/mL) rather than waiting for levels to fall below 200 — is one of the most straightforward and evidence-based strategies for preserving cognitive health with aging.
Who Should Test — and How Often
B12 testing is indicated for everyone, but certain groups should test regularly regardless of symptoms:
Vegans and vegetarians: B12 is found almost exclusively in animal-derived foods — meat, fish, eggs, and dairy. Plant foods do not contain meaningful B12 (nori and certain algae contain small amounts of questionable bioavailability). Vegans who do not supplement or eat fortified foods will develop B12 deficiency over time, though this can take years given liver stores. Testing annually is essential; supplementing at 1,000–2,000 mcg/day of cyanocobalamin or methylcobalamin is standard practice.
People over 50: Gastric acid production and intrinsic factor secretion both decline with age. Intrinsic factor is required for active B12 absorption in the terminal ileum — without it, absorption drops to less than 1% of intake (passive diffusion). High-dose oral supplementation (~1,000 mcg/day) partially compensates by exploiting passive diffusion even without intrinsic factor.
Metformin users: Metformin significantly reduces B12 absorption through multiple mechanisms; estimates suggest metformin reduces B12 levels by 20–30% over several years of use. Annual B12 testing is appropriate for everyone on metformin, and many practitioners routinely supplement B12 in this population.
For everyone else, testing B12 at a comprehensive health baseline is sufficient, with retesting every 2–3 years or more frequently if levels are in the borderline range.
Beyond Serum B12: More Sensitive Tests
Standard serum B12 has meaningful limitations as a marker of functional status. It measures total cobalamin, including forms that are bound to inactive transport proteins and not available for cellular use. The two more sensitive functional markers are:
Methylmalonic acid (MMA): MMA accumulates when the B12-dependent reaction that clears it is impaired. Elevated MMA (above 0.4 µmol/L) is a sensitive indicator of functional B12 deficiency even when serum B12 is in the normal range. It is relatively inexpensive and can be ordered without a physician's visit through most direct-to-consumer lab services.
Holotranscobalamin (active B12): Holotranscobalamin measures only the B12 that is bound to transcobalamin II — the fraction that is actually available for cellular uptake. It is a more direct measure of metabolically active B12 than total serum B12 and can detect deficiency earlier. Less widely available but increasingly offered by comprehensive testing services.
For most people, serum B12 with a target of above 500 pg/mL is sufficient. For those with borderline levels, symptoms, or high-risk status, adding MMA provides a much clearer picture of functional adequacy.
Sources
- Tucker KL, et al. "Plasma Vitamin B12 Concentrations Relate to Intake Source in the Framingham Offspring Study." American Journal of Clinical Nutrition, 2000. PubMed →
- Smith AD, et al. "Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment." PLOS ONE, 2010. PubMed →
- Green R, et al. "Vitamin B12 Deficiency." Nature Reviews Disease Primers, 2017. PubMed →
| Range Type | Value (pg/mL) | Notes |
|---|---|---|
| Standard Clinical Range | 200–900 pg/mL | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | > 500 pg/mL |
Associated with reduced all-cause mortality and extended healthspan.
Neurological symptoms can appear at levels below 400 pg/mL, and some research suggests optimal cognitive protection requires levels above 500 pg/mL. Many longevity practitioners target 600–900 pg/mL. The standard lower cutoff of 200 pg/mL identifies overt deficiency; functional deficiency causing neurological and metabolic effects can occur at levels up to 400–450 pg/mL.
|
Already have your results? See what your Vitamin B12 and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What B12 level is considered optimal for longevity?
Longevity medicine practitioners generally target B12 above 500 pg/mL, with many aiming for 600–900 pg/mL. The standard clinical lower cutoff of 200 pg/mL identifies severe deficiency, but functional neurological and metabolic effects can occur at levels between 200–400 pg/mL — a 'gray zone' where many people are classified as normal but are not optimal. A 2016 study in the journal Nutrients found that neuropsychiatric symptoms attributable to B12 deficiency appeared in patients with levels below 400 pg/mL, and that treatment at this stage significantly improved outcomes compared to waiting for levels to fall below the clinical cutoff.
Who is most at risk for B12 deficiency?
The highest-risk groups are: (1) Vegans and strict vegetarians — B12 is found almost exclusively in animal products; plant-based eaters are at near-certain risk without supplementation or fortified foods. (2) People over 50 — gastric acid production declines with age, impairing release of B12 from food proteins; additionally, atrophic gastritis (common in older adults) reduces intrinsic factor production, which is required for B12 absorption. (3) Metformin users — metformin significantly reduces B12 absorption through mechanisms that are not fully understood; B12 should be tested at least annually in anyone on metformin. (4) PPI users — proton pump inhibitors reduce gastric acid, impairing B12 liberation from food. (5) People with Crohn's disease, celiac disease, or prior gastric surgery affecting the terminal ileum, where B12 is absorbed.
What is the difference between cyanocobalamin and methylcobalamin?
Both are forms of vitamin B12, but they differ in how the body processes them. Cyanocobalamin is the synthetic form used in most supplements and fortified foods; it must be converted by the body to one of the active forms (methylcobalamin or adenosylcobalamin) before it can be used. Methylcobalamin is the naturally occurring active form; it does not require conversion and is directly usable. For most people, cyanocobalamin is effectively converted and is an appropriate, cost-effective form. However, for people with MTHFR genetic variants or other methylation impairments, methylcobalamin or hydroxocobalamin may be preferable. For treating established deficiency or severe neurological symptoms, hydroxocobalamin (given by injection) is the most reliable approach.
Can you have too much B12?
B12 toxicity from dietary or oral supplemental intake is not known to occur in humans — excess B12 is excreted in urine. Very high serum B12 (above 900–1,000 pg/mL) without supplementation can occasionally be a marker of underlying disease (liver disease, myeloproliferative disorders, solid tumors) and warrants investigation. However, high B12 from supplementation is benign. Oral doses of 1,000–5,000 mcg are commonly used for repletion in deficiency states without adverse effects.
Does B12 deficiency cause fatigue?
Yes — fatigue is among the most common symptoms of B12 deficiency, arising from two mechanisms: impaired red blood cell production (megaloblastic anemia, in which red blood cells are large and dysfunctional) and impaired cellular energy metabolism due to deficient succinyl-CoA synthesis in the citric acid cycle. However, fatigue is such a non-specific symptom that B12 deficiency is rarely identified as its cause without testing. Many people have B12 deficiency identified only incidentally on bloodwork ordered for other reasons. Testing B12 in anyone with unexplained fatigue, cognitive fog, or mood changes is straightforward and should be routine.